Antibody Responses (Videos Available)

Monday July 02, 2018 from 09:45 to 11:15

Room: N-104

318.5 Specific immunomodulation of alloantibody responses

Christian Schuetz, United States

Instructor in Surgery
Transplant Surgery
Massachusetts General Hospital

Abstract

Specific Immunomodulation of Alloantibody Responses

Christian Schuetz1, Mihail Climov2, Aarti R Patil7, Zhaouhui Wang1, Alec Andrews Roy1, Nalu Navarro-Alvarez1,5, Abraham J Matar3, David H Sachs1,6, Raimon Duran-Struuck4, Christene A Huang1.

1Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, United States; 2Department of Surgery, Division of Plastic and Reconstructive Surgery, West Virginia University, Morgantown, WV, United States; 3Department of Surgery, Emory University, Atlanta, GA, United States; 4Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States; 5Departamento de Gastroenterología , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubrirán, Mexico City, , Mexico; 6Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, United States; 7Department of Surgery, St Luke´s Roosevelt Hospital, New York, NY, United States

Introduction: Antibody (Ab) mediated rejection of transplanted organs presents a formidable barrier to solid organ transplantation. We have previously shown that intravenous (i.v.) exposure to MHC-mismatched donor peripheral blood cells using a novel, mild conditioning protocol results in B-cell tolerance with transient T-cell unresponsiveness. Here we show that B-cell tolerance is stable and allo-Ab cannot be induced even after loss of chimerism and repeated exposure to donor cells without immunosuppression.
Materials and Methods: MGH miniature swine conditioned with CD3-immunotoxin, low-dose (100cGy) total body irradiation (TBI), and a short, 45 day course of cyclosporine A, received cells i.v. from a haplo- or fully MHC-mismatched donor. Weekly immunophenotyping of peripheral blood was performed. Hematopoietic cells from donor and third-party MHC-mismatched pigs were injected subcutaneously (s.c.) +/- complete Freund’s adjuvant (CFA) monthly, starting 60 days following conditioning. Control animals with and without conditioning, but without donor HCT, were challenged in the same manner. The draining lymph nodes were analyzed by Histology and bulk RNAseq. Allo-Ab was measured by flow cytometry and complement dependent Ab mediated cellular cytotoxicity assay.
Results and Discussion:Phenotypic analysis of recipient cells during conditioning revealed that most cell populations, including CD4+ Foxp3+ Treg cells, were only partially depleted and quickly recovered to baseline. Allo-Ab responses were not detected even after repeated s.c. injections of donor cells. The addition of CFA provoked a transient, weak IgM response suggestive of an extrafollicular B-cell response with no germinal center development. Control animals consistently developed Allo-Ab responses against donor cells. Histologic analysis of draining lymph nodes shows similar morphology and presence of active Germinal centers in both groups. However, preliminary analysis reveals an abundance of FoxP3+ cells in tolerant animals. This suggests that donor cells trigger a germinal center reaction in tolerant animals that may be controlled by  memory T-follicular regulatory cells. Further histologic and transcriptome analysis of draining LN cells are currently underway and may yield additional insights into the mechanical underpinnings.
Conclusion: Stable B-cell tolerance to donor antigens across fully MHC-mismatched barriers can be induced by a novel, mild conditioning protocol that does not result in prolonged T-cell depletion. We are currently investigating the mechanism of this phenomenon. Understanding immunomodulatory mechanisms involved in controlling B-cell responses to transplantation antigens could lead to significant advances in improving transplantation outcomes.

Presentations by Christian Schuetz



© 2024 TTS2018